Yahoo
OTC Markets OTCPK - Delayed Quote USD

BioForce Nanosciences Holdings, Inc. (BFNH)

7.02 -0.18 (-2.50%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for BFNH
  • Previous Close 7.20
  • Open 7.40
  • Bid 7.11 x 10000
  • Ask 7.73 x 50000
  • Day's Range 7.02 - 7.71
  • 52 Week Range 0.18 - 10.99
  • Volume 1,500
  • Avg. Volume 11,048
  • Market Cap (intraday) 235.514M
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) --
  • EPS (TTM) 0.00
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It offers private label products with distributors and manufacturing providers. The company also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.

www.bioforceeclipse.com

3

Full Time Employees

December 31

Fiscal Year Ends

Energy

Sector

Oil & Gas E&P

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BFNH
1,110.34%
S&P 500 (^GSPC)
10.73%

1-Year Return

BFNH
777.50%
S&P 500 (^GSPC)
11.11%

3-Year Return

BFNH
242.44%
S&P 500 (^GSPC)
81.91%

5-Year Return

BFNH
440.00%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY08
Revenue 370.49k
Earnings --
Profit Margin 0.00%

Q2

FY08

Q3

FY08

Q4

FY08

0
100K
200K
300K
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -32.12%

  • Return on Equity (ttm)

    -10.15%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -97.44k

  • Diluted EPS (ttm)

    0.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    307

  • Total Debt/Equity (mrq)

    2.20%

  • Levered Free Cash Flow (ttm)

    -2.83M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: